Clinical Trial Update: GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating GOT as a neoadjuvant regimen for patients with resectable intrahepatic cholangiocarcinoma at high risk of recurrence; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING